Physician profile
Naim E Bouhussein
NPI 1932214137
$1,586.97
in general payments reported to CMS, 2019-2025
20 companies · $43.57 in 2025
The $43.57 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $575 · 2020: $253 · 2021: $196 · 2022: $290 · 2023: $143 · 2024: $86.30 · 2025: $43.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $272.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $268.38 | 2019-2023 | |
| Medtronic Vascular, INC. | $265.51 | 2019 | |
| Amgen INC. | $264.81 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $113.31 | 2019-2023 | Eliquis |
| Janssen Pharmaceuticals, INC | $101.37 | 2019 | |
| Sanofi-Aventis U.S. LLC | $98.02 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $95.62 | 2019-2023 | |
| Abbott Laboratories | $70.42 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $63.61 | 2022-2025 | Lifevest |
| Abiomed | $35.35 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $35.19 | 2020-2021 | |
| Lundbeck LLC | $33.13 | 2021 | |
| Atricure, INC. | $29.08 | 2024 | |
| Medtronic, INC. | $23.55 | 2025 | Mycarelink |
| Tactile Systems Technology INC | $19.61 | 2023 | Entre Plus, Flexitouch Plus |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $17.76 | 2024 | Barostim Neo System |
| Inspire Medical Systems, INC. | $17.14 | 2024 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.53 | 2021 | |
| Portola Pharmaceuticals, LLC | $11.49 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Naim Bouhussein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.